|
Mechanism5-HT receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date31 Jul 2009 |
100 Clinical Results associated with Luye Innomind Pharma Shijiazhuang Co., Ltd.
0 Patents (Medical) associated with Luye Innomind Pharma Shijiazhuang Co., Ltd.
100 Deals associated with Luye Innomind Pharma Shijiazhuang Co., Ltd.
100 Translational Medicine associated with Luye Innomind Pharma Shijiazhuang Co., Ltd.